![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
Carmel Medical Center Women Health Care Center - Lin Medical Center Common Sense |
---|---|
Information provided by: | Carmel Medical Center |
ClinicalTrials.gov Identifier: | NCT00803127 |
This study is designed to demonstrate the result reading clarity of the VS-SENSE is substantially equivalent to the result reading clarity of the Nitrazine pH Paper test for vaginal secretions.
Condition | Intervention |
---|---|
Vaginitis |
Device: vs-sense |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | VS-Sense Result Reading Clarity |
VAGINAL DISCHARGE
Estimated Enrollment: | 120 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | May 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
no treament |
Device: vs-sense
detection swab
|
Once informed consent has been signed, the clinician will perform the following:
Record baseline variables in the CRF. The 1st clinician will obtain a vaginal secretion sample by using the VS-SENSE swab. The 1st clinician will obtain the specimen by separating the labia to expose the vagina. The yellow tip of the VS-SENSE swab will be inserted into the vagina approximately 5 cm/ 2". The 1st clinician will use the VS-SENSE according the instructions for use - attachment 1 to the protocol.
The 1st clinician will read the VS-SENSE results and record them on the designated form (Clinician Report - VS-SENSE Result form), and fill out the table regarding the VS-SENSE reading clarity on the same form.Vaginal examination (including speculum examination) - will be performed by a 2nd clinician, masked from the results of the 1st clinician test.
The 2nd clinician will use a vaginal swab for pH measurement by Nitrazine pH Paper test. The Nitrazine pH Paper test will be performed according to strict manufacturer's instruction.
The 2nd clinician will read the results of the Nitrazine pH Paper test result, document it on the Clinician Report - pH Test Result form, and fill out the table regarding the pH test reading clarity on the same form.
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Symptomatic and asymptomatic women, ages 18 and above.
Inclusion Criteria:
Exclusion Criteria:
Contact: hadar kessary, PhD | 972-4-6277101 ext 126 | HADAR@CS-COMMONSENSE.COM |
Israel, West Galil | |
Lin Medical center | |
Haifa, West Galil, Israel |
Responsible Party: | common sense ( hadar kessary ) |
Study ID Numbers: | F-7-25.2-1 |
Study First Received: | December 4, 2008 |
Last Updated: | December 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00803127 History of Changes |
Health Authority: | Israel: The Israel National Institute for Health Policy Research and Health Services Research |
vaginal infection, color appearance |
Genital Diseases, Female Vaginitis Vaginal Diseases |
Genital Diseases, Female Vaginitis Vaginal Diseases |